This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundAcute myocardial infarction complicated by cardiogenicshock (AMI‐CS) is associated with significant morbidity and mortality. A total of 406 patients were enrolled at 80 sites between 2016 and 2020. mmol/L and cardiac power output was 0.67±0.29 watts. The primary end point was in‐hospital mortality.
Introduction The use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) in extracorporeal cardiopulmonary resuscitation (ECPR) in selected patients after out-of-hospital cardiacarrest (OHCA) is an established method if return of spontaneous circulation cannot be achieved.
Introduction The use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) in extracorporeal cardiopulmonary resuscitation (eCPR) has emerged as a treatment option for selected patients who are experiencing refractory cardiacarrest (CA).
This study aims to evaluate the outcomes of chronic opioid therapy on HFpEF patients.Methods:Studying the National Inpatient Sample (2016-2020), we identified adult HFpEF patients using the appropriate ICD-10 codes -after excluding patients with end-stage renal disease (ESRD)- and compared outcomes between chronic opioid users and non-users.
A secondary analysis evaluated outcomes for severe HF hospitalizations (cardiogenicshock, cardiacarrest, and mechanical ventilation). Centers performing at least 1 heart transplant or left ventricular assist device were classified as ATCs. of centers), 525 037 (18.3%) were admissions to ATCs (5.5%
Background:Cardiogenic shock (CS) has high morbidity and mortality rates. Regardless of CS type, Black patients were more likely to have cardiacarrest during hospitalization. Among AMI-CS hospitalizations, Black patients were less likely to receive IABP (aOR: 0.87, 95%CI: 0.82-0.93), 0.93), pLVAD (aOR: 0.79, 95%CI: 0.72-0.86),
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content